COLTENE Holding AG (LON:0QP7)

Market Cap	268.56M
Revenue (ttm)	220.92M
Net Income (ttm)	13.14M
Shares Out	n/a
EPS (ttm)	2.19
PE Ratio	20.44
Forward PE	16.34
Dividend	2.26 (4.48%)
Ex-Dividend Date	Apr 25, 2025

Volume	23
Average Volume	251
Open	48.65
Previous Close	49.10
Day's Range	48.35 - 48.65
52-Week Range	45.60 - 71.00
Beta	0.77
RSI	13.75
Earnings Date	Jul 25, 2025

About Theseus Pharmaceuticals

COLTENE Holding AG develops, manufactures, and sells disposables, tools, and equipment for dentists and dental laboratories in Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania. The company offers restoration products, including conventional composites, bulk-fill composites, CAD/CAM solutions, core build-ups, bondings, etching gels, temporary materials, luting, curing lights, characterizations, and parapulpal pins; and endodontics products, such as cold sprays, hand files, shaping and retreatment files, endo motors...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 2005
• Employees: 1,251
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QP7

Financial Performance

In 2024, COLTENE Holding AG's revenue was 250.16 million, an increase of 3.06% compared to the previous year's 242.73 million. Earnings were 20.47 million, an increase of 71.31%.